Founded in 1988 in Queensbury, N.Y., U.S., AngioDynamics is today a NASDAQ-listed public company. We are a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease. Our diverse product line includes market-leading radiofrequency ablation and NanoKnife¨ systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products.
AngioDynamics has distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, through the companyÕs consistent ability to successfully develop and bring to market new technologies and products. AngioDynamics believes it is well poised to continue that trend. Looking into the future, the company plans to bring forth a continuing stream of innovations that greatly improve patient care by providing the highest-quality, best-performing products.
- Company Name:Angiodynamics
(View Trends)
-
Headquarters: (View Map)Latham, NY, United States
-
Medical Devices
-
500 - 1,000 employees
- 1522318 Global Rank
- 405676 United States
-
Search66.62%
-
Direct21.92%
-
Referrals8.24%
-
Social2.29%
-
Display0.94%
-
Mail0.00%
- United States 94.3%
- Canada 1.2%
- India 0.8%
- Queensbury
- 10 Downloads
- 10 SDKs
- 0 Total reviews
- App Url: https://play.google.com/store/apps/details?id=com.angiodynamics.portapp
- App Support: https://www.angiodynamics.com/
- Genre: medical
- Bundle ID: com.angiodynamics.portapp
- App Size: 29.4 M
- Release Date: January 7th, 2020
- Update Date: March 23rd, 2021
Description:
AngioDynamics, Inc. (Latham, NY) is an innovative medical device company addressing the unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular access. The devices provide healthcare providers and patients with the tools to deliver high-quality patient care with a goal to improve patient outcomes.
Patients receiving ports require long-term intermittent vascular access and often are patients with cancer, blood disorders, or nutritional deficits. These devices are often implanted for greater than a year. This mobile app supports patients with implantable ports and their family members with information and education about the ports.
They are headquartered at Latham, NY, United States, and have 4 advertising & marketing contacts listed on Kochava. Angiodynamics works with Advertising technology companies such as DoubleClick.Net, LinkedIn Ads.
